Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.06M Buy
50,410
+1,114
+2% +$129K 0.65% 60
2025
Q4
$5.19M Buy
+49,296
New +$4.63M 0.56% 70
2025
Q2
Sell
-40,970
Closed -$3.68M 226
2025
Q1
$3.68M Buy
+40,970
New +$3.83M 0.48% 81
2023
Q4
Sell
-85,941
Closed -$8.85M 185
2023
Q3
$8.85M Sell
85,941
-6,265
-7% -$675K 1.24% 18
2023
Q2
$10.6M Sell
92,206
-3,185
-3% -$362K 1.38% 12
2023
Q1
$10.1M Sell
95,391
-2,124
-2% -$229K 1.34% 14
2022
Q4
$10.8M Sell
97,515
-3,143
-3% -$321K 1.46% 10
2022
Q3
$8.67M Buy
100,658
+16,109
+19% +$1.44M 1.31% 13
2022
Q2
$7.71M Buy
+84,549
New +$7.5M 1.09% 21
2020
Q4
Sell
-4,892
Closed -$387K 183
2020
Q3
$387K Sell
4,892
-135
-3% -$10.6K 0.05% 134
2020
Q2
$371K Sell
5,027
-197
-4% -$14.8K 0.06% 120
2020
Q1
$384K Sell
5,224
-487
-9% -$38.3K 0.07% 123
2019
Q4
$496K Buy
+5,711
New +$469K 0.06% 123
2013
Q4
Sell
-38,767
Closed -$1.76M 266
2013
Q3
$1.76M Sell
38,767
-4,668
-11% -$213K 0.16% 160
2013
Q2
$1.93M Buy
+43,435
New +$1.94M 0.18% 152

Other funds holding MRK

Leuthold Group's MRK Position: Q1 2026 in Review

Leuthold Group increased its Merck (MRK) stake by 2.3% in Q1 2026, buying an estimated $129K and bringing the position to 50,410 shares worth $6.06M. The position accounts for 0.65% of the portfolio, ranked #60.

Leuthold Group first reported a position in MRK in Q2 2013 and has held it in 15 quarters since. The position peaked at $10.8M in Q4 2022. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Leuthold Group held 50,410 shares of Merck worth $6.06M as of Q1 2026.
  • Leuthold Group bought 1,114 Merck shares in Q1 2026, an estimated $129K.
  • Merck made up 0.65% of Leuthold Group's portfolio in Q1 2026, its #60 holding.
  • Leuthold Group first reported a position in Merck in Q2 2013 and has held it in 15 quarters since.
  • Leuthold Group's Merck position peaked at $10.8M in Q4 2022.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Leuthold Group's 13F filing for Q1 2026, filed 6 May 2026.